Results 21 to 30 of about 26,491 (207)
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019 Background Recent studies have raised concerns about the reduced efficacy of citalopram when used concurrently with proton pump inhibitors. The aim of this study was to evaluate the associations between clinical use of citalopram and omeprazole and the ...
Wen‐Tung Wu +7 more
doaj +1 more source
Torsade de pointes caused by citalopram during the pacemaker battery‐depletion phase: A case report
Annals of Noninvasive Electrocardiology, 2022 Drug‐induced QT prolongation, primarily antiarrhythmic drugs, is a common cause of torsade de pointes (TdP). Although there have been previous reports of drug‐induced TdP in patients, it has not been well documented when caused by citalopram during the ...
Junwen Wang, Ziyi Sun, Siming Tao
doaj +1 more source
Impact of the antidepressant citalopram on the behaviour of two different life stages of brown trout [PDF]
PeerJ, 2020 Background Over the last two decades, there has been a constant increase in prescription rates of antidepressants. In parallel, neuroactive pharmaceuticals are making their way into aquatic environments at increasing concentrations.
Michael Ziegler +6 more
doaj +2 more sources
Citalopram – what you need to know about this proven antidepressant
Psychiatria i Psychologia Kliniczna, 2019 Citalopram is an antidepressant belonging to the group of selective serotonin reuptake inhibitors, a racemate consisting of two enantiomers: R-citalopram and S-citalopram, which show different pharmacological properties.
Piotr Wierzbiński
doaj +1 more source
, 2011 Clinical depression is a significant risk factor for cardiovascular diseases and confers an increased risk of mortality. Increased platelet reactivity may predispose depressed patients to cardiovascular diseases.
曾昱綸;蔣孟玲;黃德富;蘇光平;藍先元 +1 more
core +1 more source
Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial. [PDF]
PLoS ONE, 2014 A Food and Drug Administration (FDA) safety communication in August 2011 warned that citalopram was associated with a dose dependent risk of QT prolongation and recommended dose restriction in patients over the age of 60 but did not provide data for this
Lea T Drye +18 more
doaj +1 more source
Translational Psychiatry, 2023 Studies assessing associations between prenatal exposure to antidepressants, maternal depression, and offspring DNA methylation (DNAm) have been inconsistent.
Emilie Willoch Olstad +4 more
doaj +1 more source
Citalopram in anorexia nervosa
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 1997 Thirthy-two female patients who had been diagnosed as having anorexia nervosa restricting subtype according to the DSM IV (Diagnostic and Statistical Manual of Mental Disorders-IV), were enrolled in a 6-month open trial with citalopram at a starting dose of 20 mg.
PALLANTI, STEFANO +2 more
openaire +3 more sources
Ecotoxicology and Environmental SafetyCitalopram is a commonly prescribed antidepressant and selective serotonin reuptake inhibitor (SSRI). Low wastewater treatment plant removal rates facilitate its ubiquity in natural surface waters.
Jamal Rahimi, Denis Meuthen
doaj +1 more source